Category Archives: Actos

Featured Stories
Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Dozens Receive Nonsterile Simulated Saline Solution

Dozens-Receive-Nonsterile-Simulated-Saline-Solution

The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Federal Jury Awards $9 Billion in Damages in Actos Bladder Cancer Case

After deliberating for about four hours yesterday, a federal jury ordered Takeda Pharmaceuticals and Eli Lilly & Co. to pay a combined $9 billion in punitive damages to Terrence Allen, finding that the drug makers hid the bladder cancer risks … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Actos Jury Advised Takeda Officials Hid Cancer Risks

actos-hid-cancer-risk-jury-told

The federal trial that just started and involving Actos, Takeda Pharmaceutical Co.’s Type II diabetes drug, includes allegations that Takeda hid risks associated with Actos from physicians and consumers. The litigation accuses Takeda of hiding risks associated with Actos. Because … Continue reading

Posted in Actos, Pharmaceuticals |

First Bellwether Trial in Actos Multidistrict Litigation Underway

actos-litgation-begins

The first federal bellwether trial alleging that the diabetes drug Actos (pioglitazone) caused bladder cancer begins today. The trial is taking place in the U.S. District Court for the Western District of Louisiana before the Honorable Rebecca F. Doherty. The plaintiffs … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Jury Selection Completed in First Actos Bladder Cancer Bellwether Trial

actos-lawsuit-trial-jury-selection

Jury selection was completed on Monday, January 27 in the first bellwether case in the Actos bladder cancer litigation. After pretrial matters January 30, testimony will begin February 3, with the trial expected to last six weeks. This case was … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Actos Maker, Takeda, Hid Drug’s Risks from Patients, Doctors

takeda_hid_actos_risks

Another Actos lawsuit alleges that Takeda Pharmaceutical Co., the maker of the Type 2 diabetes drug, put profits before patient safety and “duped” patients. The lawsuit states that Takeda should be held liable in the cancer death of a former … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Florida Man Alleges Serious Injuries After Taking Diabetes Drug, Actos

florida_actos_bladder_cancer

A Florida man alleges that he developed bladder cancer after taking the Type 2 diabetes drug, Actos (pioglitazone), for nearly seven years. A lawsuit has been filed on behalf of the man and is just one of thousands of lawsuits … Continue reading

Posted in Actos, Pharmaceuticals |

Lawsuit Accuses Actos Makers of Placing Profits Before Patient Safety

actos_profit_over_safety

A lawsuit alleges that Asia’s largest drug maker, Takeda Pharmaceuticals, put profits before patient safety. Actos (pioglitazone), Takeda’s Type 2 diabetes drug, has been at the center of thousands of personal injury lawsuits. Takeda officials were aware, as far back … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Another Lawsuit Filed Over Allegations that Actos is Tied to Bladder Cancer

actos-lawsuit-oregon_cancer

Another lawsuit has been filed against the makers of the Type 2 diabetes drug, Actos, over allegations that the medication caused the Oregon man to develop bladder cancer. The lawsuit also alleges that the drug makers were aware of the … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Another Actos User Alleges Bladder Cancer Caused by Type 2 Diabetes Drug

new_actos_bladder_cancer_claim

A Florida woman is alleging that taking the Type 2 diabetes drug, Actos (pioglitazone), caused her to develop bladder cancer, according to a lawsuit brought against the maker of the drug, Takeda Pharmaceuticals. The woman began taking Actos from about … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Gum Disease Tied to Increased Diabetes Risk, May Lead to Increased Risks Tied to Some Type 2 Diabetes Drugs

gum_disease_linked_to_diseases

The links between dental disease and other diseases have been growing, for instance dental disease has been tied to increased risks for developing diabetes and heart disease; pregnancy complications; and, potentially, dementia. Type 2 diabetes is typically treated with any … Continue reading

Posted in Actos, Byetta Cancer, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.